PERCOLATION THEORY - APPLICATION TO THE STUDY OF THE RELEASE BEHAVIOR FROM INERT MATRIX SYSTEMS

被引:64
作者
CARABALLO, I
FERNANDEZAREVALO, M
HOLGADO, MA
RABASCO, AM
机构
[1] Departamento de Farmacia y Tecnología Farmacéutica, Cátedra de Farmacia Galénica, Facultad de Farmacia
关键词
PERCOLATION THEORY; CLUSTER; PERCOLATION THRESHOLD; INERT MATRIX; CONTROLLED RELEASE;
D O I
10.1016/0378-5173(93)90225-5
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In the present paper, release profiles obtained from matrix tablets prepared with Eudragit(R) RS-KCl and a usual eccentric machine were studied. The results were in agreement with previously reported release studies for compacts prepared using a hydraulic press. The most outstanding aspect is the study of the influence of the particle size of drug and excipient on the release behaviour of the matrices, and its evaluation on the basis of percolation theory. The influence of soluble drug loading has also been studied. This new theory has been shown to be a useful tool to explain the release profiles from inert matrix compressed tablets.
引用
收藏
页码:175 / 181
页数:7
相关论文
共 10 条
[1]  
BONNY JD, 1991, PHARM ACTA HELV, V66, P160
[2]   MODELING OF SUSTAINED-RELEASE OF WATER-SOLUBLE DRUGS FROM POROUS, HYDROPHOBIC POLYMERS [J].
GURNY, R ;
DOELKER, E ;
PEPPAS, NA .
BIOMATERIALS, 1982, 3 (01) :27-32
[3]   THE RELATIONSHIP BETWEEN SOLID FRACTION AND MECHANICAL-PROPERTIES OF COMPACTS - THE PERCOLATION THEORY MODEL APPROACH [J].
HOLMAN, LE ;
LEUENBERGER, H .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1988, 46 (1-2) :35-44
[4]   PERCOLATION THEORY - A NOVEL-APPROACH TO SOLID DOSAGE FORM DESIGN [J].
LEUENBERGER, H ;
ROHERA, BD ;
HAAS, C .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1987, 38 (1-3) :109-115
[5]   FORMATION OF A TABLET - A SITE AND BOND PERCOLATION PHENOMENON [J].
LEUENBERGER, H ;
LEU, R .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1992, 81 (10) :976-982
[6]  
LEUENBERGER H, 1989, PHARM ACTA HELV, V4, P34
[7]  
LEUENBERGER H, 1990, 2ND P WORLD C PART T, P1
[8]  
POTTER A, 1992, 6TH INTERNATIONAL CONFERENCE ON PHARMACEUTICAL TECHNOLOGY, VOLS 1-5, P90
[9]  
RABASCO AM, 1992, 1ST EUR C PHARM SCI, P71
[10]  
SALOMON JL, 1980, PHARM ACTA HELV, V55, P174